We are interested in how antibody glycosylation, production, half-life, isotype-switching, and activity are regulated during microbial infection. Dissecting the regulatory mechanisms from microbes and host guides us to develop promising vaccine and antibody therapy. We are also developing the antibody-based intervention that not only provides antibody-mediated protection but also sensitizes bacteria to antibiotics. Antibiotic resistance is the global issue, so it is of course important to understand how it emerged.
2024-11-28
2024-11-14
2024-11-07
2024-10-31
2024-10-24
2024-10-18
2024-10-10
2024-09-26
2024-09-19
2024-09-12
2024-09-05
2024-08-29
2024-08-15
2024-08-08
2024-08-02
2024-07-26
2024-07-18
2024-07-11
2024-07-04
2024-06-27
2024-06-20
2024-06-14
2024-06-07
2024-05-30
2024-05-23
2024-05-16
2024-05-09
2024-04-29
2024-04-18
2024-04-11
2024-03-28
2024-03-21
2024-03-14
2024-03-07
2024-02-22
2024-02-05
2024-01-15
2024-01-25
2024-01-18
2024-01-11
2024-01-04
2023-12-28
2023-12-21
2023-12-14
2023-12-07
2023-11-30
2023-11-23
2023-11-16
2023-11-08
2023-11-02
2023-10-24
2023-10-26
2023-10-19
2023-10-12
2023-09-28
2023-09-22
2023-08-25
2023-09-07
2023-09-01